SHL logo

Siemens Healthineers AG Stock Price

XTRA:SHL Community·€49.9b Market Cap
  • 1 Narratives written by author
  • 0 Comments on narratives written by author
  • 41 Fair Values set on narratives written by author

SHL Share Price Performance

€44.72
-7.76 (-14.79%)
€56.99
Fair Value
€44.72
-7.76 (-14.79%)
21.5% undervalued intrinsic discount
€56.99
Fair Value
Price €44.72
AnalystConsensusTarget €56.99

SHL Community Narratives

AnalystConsensusTarget·
Fair Value €56.99 21.5% undervalued intrinsic discount

AI Diagnostics Partnerships And Healthcare Demand Will Support Global Expansion Ahead

2users have liked this narrative
0users have commented on this narrative
23users have followed this narrative

Trending Discussion

Updated Narratives

SHL logo

SHL: Dividend Growth Will Drive Long-Term Upside Despite Recent Price Target Cuts

Fair Value: €56.99 21.5% undervalued intrinsic discount
23 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Snowflake Analysis

Very undervalued with proven track record.

1 Risk
5 Rewards

Siemens Healthineers AG Key Details

€23.4b

Revenue

€14.3b

Cost of Revenue

€9.0b

Gross Profit

€6.9b

Other Expenses

€2.1b

Earnings

Last Reported Earnings
Sep 30, 2025
Next Reporting Earnings
Feb 05, 2026
1.92
38.63%
9.17%
78.0%
View Full Analysis

About SHL

Founded
1896
Employees
72369
CEO
Bernhard Montag
WebsiteView website
www.siemens-healthineers.com

Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities. Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations. Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair; spare parts; medical equipment performance management; training; clinical education and e-learning; planning and design; financing; asset management; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.

Recent SHL News & Updates

Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 64% Above Its Share Price

Dec 11
Siemens Healthineers AG's (ETR:SHL) Intrinsic Value Is Potentially 64% Above Its Share Price

Recent updates

No updates